This biotech's problem is that investors became jaded by the slow commercialisation and strategy whoopsies. There are signs of a ...

No company wants sub-optimal returns on their product – and pain-management house Medical Developments International is no exception. ...

Here are four big drug/biotech stocks, LLY, RHHBY, NVS and PFE, which you should buy today for lucrative long-term returns.

Here are four big drug/biotech stocks, LLY, RHHBY, NVS and PFE, which you should buy today for lucrative long-term returns.

Mutual Fund Report for BIPIX

Mutual Fund Report for BIPIX

Swiss and Spanish firms gain joint control of Romanian fertilizer player.

Swiss and Spanish firms gain joint control of Romanian fertilizer player.